Carnosine and its methylated relative anserine are abundant in skeletal muscle and have been studied for buffering, antioxidant, and anti-glycation behaviour.
Key Takeaways
- Carnosine is beta-alanyl-L-histidine, and anserine is its methylated derivative.
- Carnosine can react with reactive carbonyl species and has been reported to limit advanced glycation end-product formation in vitro.
- The buffering role is well supported, and the performance literature around beta-alanine is reasonably consistent for certain exercise durations.
What they are
Carnosine is beta-alanyl-L-histidine, and anserine is its methylated derivative. Both are present at high concentration in vertebrate skeletal muscle, which is the main reason they entered the performance and ageing literature.
The buffering hypothesis
The imidazole ring has a pKa near physiological pH, making it an effective intracellular buffer. This is the most convincing proposed mechanism and underpins the interest in beta-alanine supplementation, which raises muscle carnosine content.
For related mechanism work, see antihypertensive peptides.
Anti-glycation and antioxidant behaviour
Carnosine can react with reactive carbonyl species and has been reported to limit advanced glycation end-product formation in vitro. Whether this occurs at physiological concentrations in vivo remains an open question rather than a settled finding.
The carnosinase problem
Serum carnosinase hydrolyses carnosine rapidly, which severely limits the usefulness of oral carnosine itself. This is why beta-alanine supplementation, rather than carnosine ingestion, is the practical route to raising muscle content.
Assessment
The buffering role is well supported, and the performance literature around beta-alanine is reasonably consistent for certain exercise durations. Other proposed benefits remain preliminary and should be described as such.
Experimental Conditions and Practical Setup
Muscle carnosine content is measured noninvasively by proton magnetic resonance spectroscopy or directly in biopsy tissue, and buffering capacity is inferred from the imidazole content. Supplementation studies run for a sufficient period to change muscle content, since acute dosing does not, and they pair the measurement with a performance endpoint.
Carnosine versus beta-alanine supplementation
| Approach | Rationale | Outcome |
|---|---|---|
| Oral carnosine | Direct supply of the dipeptide | Largely hydrolysed by serum carnosinase |
| Oral beta-alanine | Supplies the rate-limiting precursor | Raises muscle carnosine content |
| Co-ingestion with carbohydrate | Supports uptake | Modest additional effect |
| Dietary anserine | Alternative imidazole source | Less studied in humans |
Practical Notes for the Bench
- Note that serum carnosinase rapidly hydrolyses oral carnosine.
- Distinguish beta-alanine supplementation from carnosine ingestion.
- Treat anti-glycation claims as preliminary pending physiological confirmation.
Frequently Asked Questions
Why supplement beta-alanine rather than carnosine?
Because serum carnosinase breaks down ingested carnosine before it reaches muscle, while beta-alanine is the rate-limiting precursor for synthesis.
What is the best-supported mechanism?
Intracellular pH buffering via the imidazole ring, which has a pKa close to physiological pH.
Is antioxidant activity established in humans?
No. It is demonstrated in vitro; whether it occurs at physiological concentrations in vivo is unresolved.
Why supplement beta-alanine instead of carnosine?
Because serum carnosinase hydrolyses ingested carnosine before it reaches muscle, while beta-alanine is the rate-limiting precursor for endogenous synthesis.
Related Reading
- antihypertensive peptides
- marine bioactive peptides
- antioxidant peptide mechanisms
- peptide PEGylation
- solid-phase peptide synthesis
References & Further Reading
- Cesak O et al. Carnosine and Beta-Alanine Supplementation in Human Medicine: Narrative Review and Critical Assessment. Nutrients. 2023. PubMed 37049610
- Trexler ET et al. International society of sports nutrition position stand: Beta-Alanine. J Int Soc Sports Nutr. 2015. PubMed 26175657
- Peptide literature search on PubMed
- Full-text archive at PubMed Central
- FDA guidance documents on peptide drug products
Educational content for research staff. Nothing here should be read as advice on human or veterinary use of any compound.
Reviewed by Dr. Aiko Tanaka, Bioactive Peptides & Dermatological Research.